Tetsuro Yamamoto Selected Research

Tetsuro Yamamoto Research Topics

Disease

4	Inflammation (Inflammations) 11/2020 - 09/2008
4	Neoplasms (Cancer) 05/2015 - 01/2011
4	Knee Osteoarthritis 10/2012 - 09/2010
3	Hypertension (High Blood Pressure) 11/2019 - 04/2013
3	Pain (Aches) 09/2011 - 09/2010
2	Rheumatoid Arthritis 05/2022 - 02/2016
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 02/2011
2	Bone Resorption 10/2012 - 02/2011
2	Synovitis 09/2011 - 02/2011
1	Adrenocortical Carcinoma 05/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2022
1	Hyperglycemia 07/2021
1	Diabetes Complications 11/2020
1	Stroke (Strokes) 01/2019
1	Down Syndrome (Down's Syndrome) 01/2017
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Neoplasm Metastasis (Metastasis) 05/2015
1	Stomach Neoplasms (Stomach Cancer) 04/2015
1	Hemorrhage 12/2013
1	Pleurisy (Pleuritis) 12/2013
1	Adenoma (Adenomas) 04/2013
1	Hyperaldosteronism (Conn Syndrome) 04/2013
1	Hyperplasia 04/2013
1	Hereditary Angioedemas 12/2012
1	Arthralgia (Joint Pain) 10/2012
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2012
1	Osteoarthritis 09/2011
1	type 2 alpha 1 Collagenopathy 02/2011
1	Hyperuricemia 01/2010
1	Alzheimer Disease (Alzheimer's Disease) 10/2009
1	Fever (Fevers) 10/2009
1	Hyperthermia 06/2009
1	Mycoses (Diseases, Fungus) 11/2008
1	Arthus Reaction 09/2008
1	Sudden Death 07/2007
1	Cardiac Arrhythmias (Arrythmia) 07/2007
1	Leukocytosis (Pleocytosis) 12/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2017 - 02/2011
4	Hyaluronic Acid (Hyaluronan)IBA 10/2012 - 09/2010
3	Anaphylatoxin C5a ReceptorIBA 12/2013 - 09/2008
3	ribosomal protein S19IBA 12/2013 - 06/2009
3	Collagen Type II (Type II Collagen)IBA 10/2012 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 07/2011
2	SaltsIBA 11/2019 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 07/2011 - 01/2011
2	AntibodiesIBA 01/2011 - 09/2008
1	Methotrexate (Mexate)FDA LinkGeneric 05/2022
1	dupilumabIBA 01/2022
1	GlyceraldehydeIBA 07/2021
1	Advanced Glycation End ProductsIBA 11/2020
1	AldehydesIBA 11/2020
1	Threonine (L-Threonine)FDA Link 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	Peroxidase (Myeloperoxidase)IBA 11/2020
1	lactaldehydeIBA 11/2020
1	SolutionsIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	CytokinesIBA 01/2017
1	Superoxides (Superoxide)IBA 02/2016
1	SurvivinIBA 05/2015
1	Midazolam (Versed)FDA LinkGeneric 04/2015
1	Propofol (Diprivan)FDA LinkGeneric 04/2015
1	CarrageenanIBA 12/2013
1	Neutralizing AntibodiesIBA 12/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2013
1	AldosteroneIBA 04/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2013
1	PotassiumIBA 04/2013
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 04/2013
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 04/2013
1	Complement System Proteins (Complement)IBA 12/2012
1	Collagen Type I (Type I Collagen)IBA 10/2012
1	DiamondIBA 01/2012
1	Vitamin D FDA LinkGeneric 09/2011
1	AntioxidantsIBA 09/2011
1	Glucosamine (Dona)IBA 09/2011
1	dimethyl sulfone (methylsulfonylmethane)IBA 09/2011
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 09/2011
1	MicronutrientsIBA 09/2011
1	Therapeutic UsesIBA 07/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Uric Acid (Urate)IBA 01/2010
1	ManganeseIBA 06/2009
1	ThapsigarginIBA 06/2009
1	LigandsIBA 06/2009
1	fucogalactanIBA 11/2008
1	Connexin 43 (Connexin43)IBA 07/2007
1	CalreticulinIBA 07/2007
1	cysteinyl-leukotrieneIBA 12/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 05/2015 - 07/2011
2	Transplantation 07/2011 - 01/2011
1	Adrenalectomy 05/2022
1	Hepatectomy 05/2015
1	Gastrostomy 10/2009